Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: A proton MR spectroscopic imaging and MRI study

Neurology

Volumn 49, Issue 6, 1997, Pages 1513-1521

  Schuff, Norbert ^a,b   Amend, D ^a   Ezekiel, F ^a   Steinman, S K ^a,b   Tanabe, J ^a,b   Norman, D ^b   Jagust, W ^d   Kramer, J H ^c   Mastrianni, J A ^b   Fein, G ^a,b,c   Weiner, M W ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; BRAIN SIZE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; GLIA CELL; GLIOSIS; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0031454126     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.6.1513     Document Type: Article

References (41)

1. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991;253:1380-1386.
2. Seab JP, Jagust WJ, Wong ST, Roos MS, Reed B, Budinger TF. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8:200-208.
3. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
4. Jack CR, Petersen CR, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
5. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. Am Soc Neuroradiol 1994;15:929-937.
6. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992;59:55-61.
7. Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40-47.
8. 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167-174.
9. Longo R. Giorgini A, Magnaldi S, Pascazio L, Ricci C. Alzheimer's disease histologically proven studied by MRI and MRS: two cases. Magn Reson Imaging 1993;11:1209-1215.
10. Shiino A, Matsuda M, Morikawa S, Inubushi T, Akiguchi I, Handa J. Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993;39:143-147.
11. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994;32:110-115.
12. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72.
13. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995;13:457-462.
14. 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 1996;44:133-138.
15. Kattapong VJ, Brooks WM, Wesley MH, Kodituwakku PW, Rosenberg GA. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia. Arch Neurol 1996;53:678-680.
16. MacKay S, Ezekiel F, Di Sclafani V, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996;198:537-545.
17. Tedeschi G, Bertolino A, Lundborn N, et al. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 1996;47:696-704.
18. Ende G, Laxer KD, Knowlton RC, et al. Proton MRSI reveals bilateral hippocampal metabolite changes in temporal lobe epilepsy. Radiology 1997;202:809-818.
19. Cendes F, Andermann F, Preul MC, Arnold DL. Lateralization of temporal lobe epilepsy based on regional metabolite abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol 1994;35:211-216.
20. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy -presurgical localization with proton chemical shift imaging. Radiology 1994;193:465-472.
21. 1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease. Fortschr Röntgenstr 1995;163:230-237.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994;31:645-651.
25. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992;16:620-633.
26. Jernigan TL, Press GA, Hesselink JR. Methods for measuring brain morphologic features on magnetic resonance images: validation and normal aging. Arch Neurol 1990;47:27-32.
27. SAS II. SAS/SAT user's guide. Release 6.03, 6.03 ed. Cary, NC: SAS Institute, 1988.
28. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750.
29. Mori E, Hirono N, Yamashita H, et al. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry 1997;154:18-24.
30. Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis. Magn Reson Imaging 1992;10:471-485.
31. Kwo-On-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust WJ. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res 1994;667:167-174.
32. West MJ, Coleman PD, Flood DG, Tronscoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-772.
33. Canning DR, McKeon RJ, DeWitt DA, et al. Beta-amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 1993;124:289-298.
34. Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of MR visible neurochemicals in gray and white matter of the human brain. Magn Reson Med 1995;33:755-759.
35. 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med 1996;36:21-29.
36. Price JL. The relationship between tangle and plaque formation during healthy aging and mild dementia. Neurobiol Aging 1993;14:661-663.
37. West MJ. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 1993;14:287-293.
38. Brayne C, Calloway P. Normal aging, impaired cognitive function, and senile dementia of the Alzheimer's type: a continuum? Lancet 1988;4:1265-1267.
39. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282.
40. 1H spectroscopic imaging by data extrapolation. Magn Reson Med 1996;35:678-687.
41. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myoinositol with proton MR spectroscopy. Radiology 1993;187:433-437.